VERU INC. Current Liabilities
VERU INC. (VERU) had Current Liabilities of $6.16 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-10
- 2026-06-30: Liabilities, Current $6.16M.
- 2026-03-31: Liabilities, Current $5.39M.
- 2025-12-31: Liabilities, Current $7.13M.
- 2025-09-30: Liabilities, Current $7.79M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.16M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $5.39M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $7.13M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $7.79M 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $6.68M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $5.62M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $6.35M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $11.87M 10-K · filed 2025-12-17 | |
| 2024-06-30 | $10.62M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $9.57M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $16.62M 10-Q · filed 2024-04-01 | |
| 2023-09-30 | $17.81M 10-K · filed 2024-12-16 | $20.28M 10-K · filed 2023-12-08 |
| 2023-06-30 | $26.44M 10-Q · filed 2024-08-08 | $27.69M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $34.25M 10-Q · filed 2024-05-08 | $39.26M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $37.48M 10-K/A · filed 2024-04-01 | $40.08M 10-Q · filed 2023-02-09 |
| 2022-09-30 | $38.71M 10-K/A · filed 2024-04-01 | $41.44M 10-K · filed 2022-12-05 |
| 2022-06-30 | $27.81M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $21.18M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $13.94M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $15.77M 10-K · filed 2022-12-05 | |
| 2021-06-30 | $17.21M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $18.87M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $17.06M 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $14.73M 10-K · filed 2021-12-02 | |
| 2020-06-30 | $17.37M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $16.82M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $16.91M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $14.02M 10-K · filed 2020-12-10 | |
| 2019-06-30 | $11.66M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $11.27M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $9.74M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $13.55M 10-K · filed 2019-12-12 | |
| 2018-06-30 | $12.72M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $10.59M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $6.23M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $5.49M 10-K · filed 2018-12-13 | |
| 2017-06-30 | $4.87M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $3.41M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $4.37M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $3.35M 10-K · filed 2018-01-02 | |
| 2016-06-30 | $4.99M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $4.92M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $4.48M 10-Q · filed 2016-02-02 | |
| 2015-09-30 | $4.23M 10-K · filed 2016-12-12 | |
| 2015-06-30 | $4.61M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $4.65M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $3.45M 10-Q · filed 2015-02-03 | |
| 2014-09-30 | $3.38M 10-K · filed 2015-12-02 | |
| 2014-06-30 | $3.39M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $5.13M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $4.89M 10-Q · filed 2014-02-03 | |
| 2013-09-30 | $3.47M 10-K · filed 2014-12-02 | $3.41M 10-K · filed 2013-12-03 |
| 2013-06-30 | $4.82M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $6.29M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $5.65M 10-Q · filed 2013-01-30 | |
| 2012-09-30 | $5.86M 10-K · filed 2013-12-03 | |
| 2012-06-30 | $5.13M 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $5.00M 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $3.93M 10-Q · filed 2012-01-31 | |
| 2011-09-30 | $2.29M 10-K · filed 2012-12-04 | |
| 2011-06-30 | $1.50M 10-Q · filed 2011-08-05 | |
| 2010-09-30 | $1.94M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |